AICAR-Induced Activation of AMPK Inhibits TSH/SREBP-2/HMGCR Pathway in Liver.

AICAR-Induced Activation of AMPK Inhibits TSH/SREBP-2/HMGCR Pathway in Liver.
复制标题

AICAR 诱导的 AMPK 激活抑制肝脏中的 TSH/SREBP-2/HMGCR 通路

DOI:
10.1371/journal.pone.0124951
复制
发表时间:
2015
期刊:
影响因子:
3.7
通讯作者:
Zhao J
Zhao J
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Liu S;Jing F;Yu C;Gao L;Qin Y;Zhao J

文献摘要

参考文献

被引文献

相似文献

我们先前的研究发现,促甲状腺激素促进肝脏中固醇调节元件结合蛋白-2(SREBP-2)的表达,抑制AMP激活的蛋白激酶(AMPK)活性,但尚不清楚TSH、AMPK与SREBP-2是否有直接联系。在这里,我们证明了5-氨基咪唑-4-羧酰胺核糖核苷(AICAR)诱导的AMPK的激活直接抑制了胆固醇生物合成的关键酶SREBP-2及其靶基因HMGCR和HMGCS的表达,并抑制了TSH刺激的HepG2细胞SREBP-2的上调;在TSH受体敲除小鼠中也得到了类似的结果。此外,进化上保守的丝氨酸/苏氨酸激酶AMPK使SREBP-2前体和核型中的苏氨酸残基磷酸化,TSH与AMPK相互作用影响SREBP-2的磷酸化。这些发现可能代表了AMPK改善亚临床甲状腺功能减退症(SCH)患者高TSH引起的肝脏脂肪变性和高胆固醇血症的分子机制。
Our previous study found that thyroid-stimulating hormone promoted sterol regulatory element-binding protein-2 (SREBP-2) expression and suppressed AMP-activated protein kinase (AMPK) activity in the liver, but it was unclear whether there was a direct link between TSH, AMPK and SREBP-2. Here, we demonstrate that the 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR)-induced activation of AMPK directly inhibited the expression of SREBP-2 and its target genes HMGCR and HMGCS, which are key enzymes in cholesterol biosynthesis, and suppressed the TSH-stimulated up-regulation of SREBP-2 in HepG2 cells; similar results were obtained in TSH receptor knockout mice. Furthermore, AMPK, an evolutionally conserved serine/threonine kinase, phosphorylated threonine residues in the precursor and nuclear forms of SREBP-2, and TSH interacted with AMPK to influence SREBP-2 phosphorylation. These findings may represent a molecular mechanism by which AMPK ameliorates the hepatic steatosis and hypercholesterolemia associated with high TSH levels in patients with subclinical hypothyroidism (SCH).
DOI: 10.1016/j.cmet.2005.04.010
发表时间: 2005-06-01
期刊: CELL METABOLISM
影响因子: 29
作者:
Sundqvist, A;Bengoechea-Alonso, MT;Ericsson, J
通讯作者: Ericsson, J
DOI: 10.1126/science.1215327
发表时间: 2012-05-18
期刊: Science (New York, N.Y.)
影响因子: --
作者:
Hawley SA;Fullerton MD;Ross FA;Schertzer JD;Chevtzoff C;Walker KJ;Peggie MW;Zibrova D;Green KA;Mustard KJ;Kemp BE;Sakamoto K;Steinberg GR;Hardie DG
通讯作者: Hardie DG
DOI: 10.2337/diabetes.54.5.1331
发表时间: 2005-05-01
期刊: DIABETES
影响因子: 7.7
作者:
Foretz, M;Ancellin, N;Viollet, B
通讯作者: Viollet, B
DOI: 10.1016/j.jhep.2012.02.027
发表时间: 2012-07-01
影响因子: 25.7
作者:
Chung, Goh Eun;Kim, Donghee;Lee, Hyo-Suk
通讯作者: Lee, Hyo-Suk
DOI: 10.1016/j.bbrc.2011.07.078
发表时间: 2011-08-26
影响因子: 3.1
作者:
Knowles, Christi;Liu, Zhi-Mei;Yang, Jian
通讯作者: Yang, Jian